Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CDK9 modulators(Cyclin-dependent kinase 9 modulators), DAT modulators(Dopamine transporter modulators), TFEB modulators(transcription factor EB modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H34N2O3 |
InChIKeyWBEFXEHFEBYZEJ-UHFFFAOYSA-N |
CAS Registry2358754-22-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | CN | 03 Jun 2024 |